Spectrum Pharmaceuticals Inc (SPPI) Return on Assets ROA from the first quarter of 2023 to first quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket
 


Spectrum Pharmaceuticals Inc   (NASDAQ: SPPI)


Spectrum Pharmaceuticals Inc 's ROA from the first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Spectrum Pharmaceuticals Inc 's ROA in the first quarter of 2023?
Spectrum Pharmaceuticals Inc recorded a cumulative net loss of $-65 million during 12 months ending in the first quarter of 2023, resulting in a negative return on assets (ROA) of -63.89%.

However, within the Healthcare sector 827 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2023 quarter, so far to 4886, from total ROA ranking in the fourth quarter of 2022 at 5771.

What is ROA?



Return On Assets (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Total Assets Change 8.43 % -7.17 % -19.18 % -54.91 % -44.86 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -65 -75 -106 -117 -138
Return On Assets (TTM) -63.89 % -75.7 % -104.48 % -107.99 % -104.32 %
SPPI's Total Ranking # 4886 # 5771 # 5279 # 5416 # 5351
Total Assets (TTM) in million 107 102 118 79 99
Seq. Total Assets Change 4.32 % -13.44 % 50.02 % -19.95 % -10.69 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 377
Sector # 828
Overall # 4784

Return On Assets Statistics
High Average Low
29.38 %
-33.07 %
-106.91 %
(Jun 30 2012)   (Jun 30 2022)





Financial Statements
Spectrum Pharmaceuticals Inc 's Assets $ 107 million SPPI's Balance sheet
Spectrum Pharmaceuticals Inc 's Income $ -5 million Quarterly SPPI's Income Statement
SPPI's Income by Division See SPPI's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
Y / Y Total Assets Change -7.17 % -43.45 % -25.89 % -32.61 % -19.81 %
Total Assets in million 102 110 195 263 391
Y / Y Net Income Change - - -67.2 % - -
Net Income in million -75 -159 10 32 0
Annual Return On Assets -73.57 % -143.68 % 5.36 % 12.11 % -0 %




More Return On Assets Ratios
SPPI's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SPPI's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SPPI's Competitors
Subscribers only: Roa for Spectrum Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for SPPI's Customers

You may also want to know
SPPI's Roi SPPI's Inventory Turnover Ratio SPPI's Growth Rates SPPI's Dividend Comparisons
SPPI's Profitability Ratios SPPI's Asset Turnover Ratio SPPI's Dividend Growth
SPPI's Roe SPPI's Valuation Ratios SPPI's Financial Strength Ratios SPPI's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2023, within Healthcare Sector ROA


Date modified: 2026-09-08T15:10:57+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.